Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

NCT04995198 is registered in ClinicalTrials.gov with Prostate Cancer Clinical Trials Consortium as lead sponsor.

NCT NCT04995198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04995198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Lead sponsor
Prostate Cancer Clinical Trials Consortium
Phase
Observational
Overall status
Recruiting
Start date
May 3, 2021
Completion date
December 31, 2037
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer